<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05045157</url>
  </required_header>
  <id_info>
    <org_study_id>CHD21_0024</org_study_id>
    <nct_id>NCT05045157</nct_id>
  </id_info>
  <brief_title>Effectiveness of Percutaneous Pulley Release With Infiltration, Versus Infiltration Alone in Trigger Finders</brief_title>
  <acronym>SECOIA</acronym>
  <official_title>Effectiveness of Percutaneous A1 Pulley Release Under Ultrasound Guidance Associated With Infiltration, Versus Infiltration Alone, in Patients With Trigger Finders Who Have Failed a First Infiltration: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Departemental Vendee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Departemental Vendee</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Trigger finger is a mechanical problem characterized by pain and catching of digit in&#xD;
      flexion.&#xD;
&#xD;
      Histological changes of A1 pulley and synovial proliferation have been identified as factors&#xD;
      that prompt trigger finger The first-line treatment of trigger finger is conservative with&#xD;
      splinting and corticosteroid injection.&#xD;
&#xD;
      If the first infiltration fails, either a second infiltration or surgical sectioning of the&#xD;
      pulley is proposed.&#xD;
&#xD;
      Surgery can be performed by several techniques (open section, percutaneous section with&#xD;
      palpatory guidance, or under ultrasound guidance).&#xD;
&#xD;
      Percutaneous A1 pulley release under ultrasound guidance consists of cutting the A1 pulley by&#xD;
      a percutaneous insertion with small needle under local anaesthesia.&#xD;
&#xD;
      The hypothesis of the study is that percutaneous A1 pulley release under ultrasound guidance&#xD;
      followed by a corticosteroid injection would be more effective than a second corticosteroid&#xD;
      injection alone on complete resolution of the trigger finger symptoms&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2025</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness of pulley section with ultrasound guidance combined with corticosteroid infiltration versus corticosteroid alone on complete resolution of trigger finger's symptoms</measure>
    <time_frame>1 year postoperatively</time_frame>
    <description>Trigger finger's symptoms defined by a clinical Quinnell score ≤1 without the use of an alternative therapy</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Trigger Finger</condition>
  <arm_group>
    <arm_group_label>percutaneous A1 pulley release with corticosteroid injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>corticosteroid injection alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous A1 Pulley Release Under Ultrasound Guidance</intervention_name>
    <description>the A1 pulley is cut off with Ultrasound guidance by a percutaneous insertion of the small needle under local anaesthesia.</description>
    <arm_group_label>percutaneous A1 pulley release with corticosteroid injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Corticosteroid injection</intervention_name>
    <description>corticosteroid injection is performed</description>
    <arm_group_label>corticosteroid injection alone</arm_group_label>
    <arm_group_label>percutaneous A1 pulley release with corticosteroid injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient ≥ 18 years old,&#xD;
&#xD;
          -  Presence of a trigger finger (thumb or long fingers) to be treated&#xD;
&#xD;
          -  Quinnell score &gt;1&#xD;
&#xD;
          -  Episode of trigger characterized on questioning or clinical examination&#xD;
&#xD;
          -  Failure of a first corticosteroid infiltration ≥ 3 months before inclusion- Thickening&#xD;
             A1 pulley on ultrasound ≥ 0.5 mm&#xD;
&#xD;
          -  Patient who has the capacity to understand the protocol and has given consent to&#xD;
             participate in the research,&#xD;
&#xD;
          -  Patient with social security coverage&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of several symptomatic fingers requiring treatment by ultrasound-guided&#xD;
             section of the pulley&#xD;
&#xD;
          -  Patient who are pregnant, breastfeeding, or who have the potential to become pregnant&#xD;
             without effective contraception at the time of inclusion&#xD;
&#xD;
          -  Known allergy to corticoid (Hydrocortancyl®) including its excipients ((benzyl&#xD;
             alcohol, sodium carmellose, sodium chloride, polysorbate 80)&#xD;
&#xD;
          -  Known allergies to lidocaine&#xD;
&#xD;
          -  Ongoing anticoagulant treatments (AVK, New Oral Anti-Coagulants)&#xD;
&#xD;
          -  Local or general infection, or suspicion of infection&#xD;
&#xD;
          -  Live vaccines&#xD;
&#xD;
          -  Evolving viruses (hepatitis, herpes, varicella, shingles)&#xD;
&#xD;
          -  Severe or uncontrolled hypertension&#xD;
&#xD;
          -  Unbalanced diabetes&#xD;
&#xD;
          -  Underlying progressive cardiovascular disease&#xD;
&#xD;
          -  Hemodialysis patients&#xD;
&#xD;
          -  Prosthesis on the finger to be treated&#xD;
&#xD;
          -  Echographic tendon fissure&#xD;
&#xD;
          -  Inflammatory disease (rheumatoid arthritis, spondyloarthritis, connective tissue&#xD;
             diseases, etc.) with tenosynovitis.&#xD;
&#xD;
          -  History of surgery on the fingers&#xD;
&#xD;
          -  Dupuytren's disease&#xD;
&#xD;
          -  Patient participating in another interventional clinical research protocol involving a&#xD;
             drug or medical device&#xD;
&#xD;
          -  Patient under guardianship, curators or legal protection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Grégoire Cormier, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHD Vendée</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Agnès Dorion</last_name>
    <phone>251446380</phone>
    <phone_ext>+33</phone_ext>
    <email>agnes.dorion@chd-vendee.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hopital Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Jimmi GROSS, Dr</last_name>
      <phone>149812711</phone>
      <phone_ext>+33</phone_ext>
      <email>jimmygross07@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHD Vendée</name>
      <address>
        <city>La Roche Sur Yon 9</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Grégoire CORMIER, Dr</last_name>
      <phone>251446197</phone>
      <phone_ext>+33</phone_ext>
      <email>gregoire.cormier@chd-vendee.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Benoît LE GOFF, Dr</last_name>
      <phone>240084824</phone>
      <phone_ext>+33</phone_ext>
      <email>Benoit.LEGOFF@chu-nantes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Lariboisière</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Jérémie Maillet, Dr</last_name>
      <phone>149958631</phone>
      <phone_ext>+33</phone_ext>
      <email>maillet.jerem@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>September 7, 2021</study_first_submitted>
  <study_first_submitted_qc>September 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2021</study_first_posted>
  <last_update_submitted>October 5, 2021</last_update_submitted>
  <last_update_submitted_qc>October 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Trigger Finger Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

